WHO ICTRP trial
Evaluation of aggressiveness and neoadjuvant chemotherapy in patients with…
ChiCTR2300073227 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2300073227 |
|---|---|
| Public title | Evaluation of aggressiveness and neoadjuvant chemotherapy in patients with squamous cell carcinoma of head and neck by energy spectrum CT and MRI functional imaging |
| Scientific title | Evaluation of aggressiveness and neoadjuvant chemotherapy in patients with squamous cell carcinoma of head and neck by energy spectrum CT and MRI functional imaging |
| Primary sponsor | Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Diagnostic test |
| Phase | 0 |
| Countries | China |
| Conditions | squamous cell carcinoma of head and neck |
| Interventions | Gold Standard:The pathological diagnosis was head and neck squamous cell carcinoma.;Index test:sensitivity; specificity; accuracy; positive predictive value; negative predictive value |
| Registration date | Jul 4, 2023 |
| Target size | Target condition:274;Difficult condition:0 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: